$0.4249
In chiusura: Aug 29 EDT
$0.4299
0.005001.18%
Pre-mercato: 8:33 AM EDT
IGC Pharma segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di IGC Pharma utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
IGC | IGC Pharma | -$0.02 | -$0.02 | — | — | $412.00K | $441.00K | — | — | 11/11/2025 | |
IGC | IGC Pharma | -$0.03 | -$0.03 | -$0.02 | 33.33% | $272.00K | $327.60K | $328.00K | 0.12% | 08/14/2025 | |
IGC | IGC Pharma | -$0.04 | -$0.02 | -$0.01 | 50.00% | $295.00K | $305.00K | $330.00K | 8.20% | 06/27/2025 | |
IGC | IGC Pharma | -$0.09 | -$0.03 | -$0.02 | 33.33% | $204.00K | $204.00K | $257.00K | 25.98% | 02/18/2025 | |
IGC | IGC Pharma | -$0.05 | -$0.03 | -$0.02 | 33.33% | $291.00K | $300.00K | $412.00K | 37.33% | 11/12/2024 | |
IGC | IGC Pharma | -$0.04 | -$0.04 | -$0.03 | 25.00% | $555.00K | $620.00K | $272.00K | -56.13% | 08/08/2024 | |
IGC | IGC Pharma | -$0.08 | -$0.04 | -$0.04 | 0.00% | $166.00K | $190.00K | $295.00K | 55.26% | 06/24/2024 | |
IGC | IGC Pharma | -$0.04 | — | -$0.09 | — | $332.00K | — | $204.00K | — | 02/14/2024 | |
IGC | IGC Pharma | -$0.05 | — | -$0.05 | — | $202.00K | — | $291.00K | — | 11/13/2023 | |
IGC | IGC Pharma | -$0.05 | — | -$0.04 | — | $212.00K | — | $555.00K | — | 08/10/2023 | |
IGC | IGC Pharma | -$0.12 | — | -$0.08 | — | $122.00K | — | $166.00K | — | 07/07/2023 | |
IGC | IGC Pharma | -$0.05 | — | -$0.04 | — | $142.00K | — | $332.00K | — | 02/14/2023 | |
IGC | IGC Pharma | -$0.09 | — | -$0.05 | — | $56.00K | — | $202.00K | — | 11/01/2022 | |
IGC | IGC Pharma | -$0.04 | — | -$0.05 | — | $77.00K | — | $212.00K | — | 08/08/2022 | |
IGC | IGC Pharma | -$0.07 | — | -$0.12 | — | $81.00K | — | $122.00K | — | 06/22/2022 | |
IGC | IGC Pharma | -$0.06 | — | -$0.05 | — | $108.00K | — | $142.00K | — | 02/10/2022 | |
IGC | IGC Pharma | $0.04 | — | -$0.09 | — | $125.00K | — | $56.00K | — | 10/29/2021 | |
IGC | IGC Pharma | -$0.05 | — | -$0.04 | — | $584.00K | — | $77.00K | — | 08/11/2021 | |
IGC | IGC Pharma | -$0.08 | — | -$0.07 | — | $29.00K | — | $81.00K | — | 06/14/2021 | |
IGC | IGC Pharma | -$0.04 | — | -$0.06 | — | $573.00K | — | $108.00K | — | 02/13/2021 | |
IGC | IGC Pharma | -$0.03 | — | $0.04 | — | $1.82M | — | $125.00K | — | 11/22/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q1 | 2025-08-14 | $-0.02 | $-0.03 | 33.3 % |
Q4 | 2025-06-27 | $-0.01 | $-0.02 | 50.0 % |
Q3 | 2025-02-18 | $-0.02 | $-0.03 | 33.3 % |
Q2 | 2024-11-12 | $-0.02 | $-0.03 | 33.3 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q1 | 2025-08-14 | $328.00K | $327.60K | 0.12 % |
Q4 | 2025-06-27 | $330.00K | $305.00K | 8.20 % |
Q3 | 2025-02-18 | $257.00K | $204.00K | 26.0 % |
Q2 | 2024-11-12 | $412.00K | $300.00K | 37.3 % |
Si prevede che IGC Pharma (IGC) fornisca risultati il novembre 11, 2025. Gli ultimi risultati sono stati pubblicati il agosto 14, 2025 per il Q1.
L'EPS effettivo era $-0.02, che superato la stima di $-0.03.
Le entrate effettive sono state $328K, che superato la stima di $327.6K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.